Efficacy and safety of hydroxychloroquine for Japanese patients with rheumatoid arthritis
Phase 2
- Conditions
- rheumatoid arthritis
- Registration Number
- JPRN-UMIN000023989
- Lead Sponsor
- Division of Rheumatology, Keio University School of Medicine
- Brief Summary
The addition of HCQ to csDMARDs was effective, with no new safety signal in patients with RA.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1) Pregnancy or hope to bear a child 2) Contraindication to HCQ, e.g. history of retinopathy and hypersensitivity to 4-aminoquinoline 3) Uncontrollable diabetes mellitus 4) Porphyria 5) Psoriasis 6) G6PD deficiency 7) Ineligible for the study judged by physicians
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method